INTRODUCTION
A literature search was conducted using PubMed and Ovid, with the term "fibromuscular dysplasia" or "seg mental arterial mediolysis" and "mesenteric" to extract studies published in the last 55 years for fibromuscular dysplasia and in the last 21 years for segmental arterial mediolysis. We summarized the available information on demographics, clinical symptoms, image studies, histological findings, treatment, and clinical course.
FIBROMUSCULAR DYSPLASIA

Clinical characteristics
The detailed clinical and pathological classification of fibro muscular dysplasia (FMD) was first reported by Harrison and McCormack in 1971 [1] . Since then, several studies regarding clinical course and histological data have been published, and recently, data from the first 447 patients from the United States Registry (US Registry) for FMD have been reported [1] . FMD is a noninflammatory, non atherosclerotic arterial disease of the mediumsized arteries throughout the body, which could lead to ar terial stenosis, occlusion, aneurysm, and dissection [2] . The details of the disease have not yet been clarified; however, it is typically found in the renal, extracranial, carotid, and vertebral arteries [2] . The disease is rare, with a frequency of 0.02%, predominantly occurring in women (91%) with a mean age of 55.7 ± 13.1 years especially in the Caucasian (95.4%) [2] . The mean patient age at first symptom or sign of FMD was 47.2 years (range, 583 years) [2] . The mecha nisms underlying the pathogenesis of FMD are still poorly understood; however, smoking, hormones, HLADRw6 polymorphism, and physiological stimulation have been reported to be risk factors [3] . For example, a significant doseresponse relationship between cigarette smoking and the presence of FMD has been reported, with an odds ratio of 8.6 when having smoked more than 10 packyears of cigarettes [3] . The risk of HLADRw6 was reported with an odds ratio of 5.0, adjusted for the level of smoking [3] . FMD can occur in any mediumsized arteries through out the body, and dissection and aneurysm have been identified in 19.7% and 17.0% of FMD patients, re spectively. The three major sites affected with dissection are the carotid arteries (14.8% of all patients enrolled), followed by renal arteries (4.3%), and vertebral ar teries (3.4%) [2, 4] . The three major sites affected with aneurysm are the renal arteries (5.6% of all patients enrolled), followed by carotid arteries (3.6%), and the aorta (3.4%) [2] . FMD in abdominal lesions, classified as mesenteric FMD, which is caused by the celiac and mesenteric arteries, is a rare condition and often presents as an incidental diagnosis [2] . On the basis of the US Registry data, mesenteric ischemia was reported in only 1.3% of cases, with aneurysm and dissection in these vessels accounting for 6.8% and 22.3% of all cases reported, respectively [2] .
Symptoms and imaging
The clinical symptoms depend on the vessels involved. When the renal arteries are affected, renovascular hypertension can be observed. Thus, when the carotid arteries are affected, headache, pulsatile tinnitus, and dizziness are the major symptoms [2] . Mesenteric FMD involves the celiac and mesenteric arteries; therefore, mesenteric ischemic symptoms occur, including unspecific abdominal pain. We reviewed the literature describing the cases and have presented the information in Table 1 [537]
. Our literature review summarized a total of 39 cases of mesenteric FMD, showing predominance in women, as reported, and the median age was 45.2 years (range: 1978 years). Regarding the risk factors, four patients smoked (10%), two patients had smoking histories (5%), and one patient had taken oral contraceptive pills (2.6%). The most common presenting symptom was abdominal pain (62%), followed by hypertension, diarrhea, nausea or vomiting, and headache. Although approximately 80% of cases showed symptom improvement, eight patients (20%) died because of the severity of the intestinal Reflecting the changes in stenosis, dissection, and aneurysm in the mediumsized arteries, FMD leads to the narrowing of the vasculature and shows a beaded appearance [38] . Therefore, catheterbased angiography has been considered to be the gold standard imaging modality; however, recent progress in imaging, such as computed tomography (CT) with high resolution, could support the diagnoses by determining the vessels affected by the disease. With the information obtained from imaging, the disease is classified into four types: multifocal, which comprises 62% of cases, showing multiple stenosis and stringofbeads; tubular, which comprises 14% of cases, showing long concentric stenosis; focal, which comprises 7% of cases, showing short stenosis of less than 1 cm; and mixed [39] . Our summary also showed aneurysms, stenosis, dissection, and occlusions in the cases for which information was available.
Histology
Histopathological findings are characteristics of the disease; thinned media and thickened fibromuscular ridges in which the arterial muscle is replaced by the fibroplasia can be observed. Based on this, the characteristic classification of FMD is essentially based on the arterial layer in which the dysplasia is predominant: intimal fibroplasia, medial fibroplasia, perimedial fibroplasia, medial hyperplasia, and adventitial fibroplasia [4043] . Intimal fibroplasia, a relatively rare form of the disease, is characterized by focal eccentric or circumferential protuberant intimal proliferation. Medial fibroplasia, the most common type, accounts for more than 70% of this disorder, and angiography shows a typical "string of beads" appearance. Perimedial fibroplasia is the secondmost common form of this disorder and is characterized by the accumulation of circumferential aggregations of elastic tissue between the media and the adventitia. Medial hyperplasia is an uncommon form and is characterized by apparent hyperplasia of normal medial smooth muscle with minimal architectural disorganization. Adventitial fibroplasia is characterized by collagenous fibroplasia encircling the adventitia and extending into the surrounding periarterial fibroadipose tissue [20] . In our case summary, fibromuscular change was confirmed histologically in the medial layer in 10 patients (26%), the intimal layer in 9
patients (23%), in both layers in 5 patients (13%), and in the adventitia layer in 1 patient (2.6%) ( Table 1) .
Treatment
The longterm outcomes of this disease entity have not been clarified to date, and no randomized clinical trials have been conducted to develop a standard treatment for this disease. Therapeutic options have been chosen on the basis of factors such as disease location, symptoms, prior history of symptoms, and the presence and size of aneurysms.
Given that FMD often shows ischemic changes causing hypertension and stroke, most patients are treated with antiplatelet, antithrombotic, and antihypertensive therapy [44] .
Antihypertensive medications are administered to 71.7% of patients. The median number of medications patients received was one, and 21.5% of patients received three or more antihypertensive medications. The most commonly used agents were betablockers (40.0%), diuretics (31.3%), and calcium channel antagonists (25.7%). A total of 21.0% of patients received an angiotensinconverting enzyme inhibitor, 21.6% received an angiotensin receptor blocking agent, and 0.8% received both [44] . The use of antihypertensive agents is related to the history of hypertension medication, body mass index, and renal function [44] . The use of antiplatelet treatment is associated with cerebrovascular involvement [44] ; however, for this entity of medicines, further studies are necessary to determine the clinically meaningful patient outcomes. In our case 38 [36] summary, insufficient information about medications was provided; thus, the actual number treated with antihypertensive therapy might be lower than 18% (Table 1) . Anticoagulation therapy was attempted for two patients (5%), including one patient each receiving warfarin and aspirin. Vascular intervention and surgery for revasculari zation are considered with the appropriate clinical symptoms and are rarely performed other than for the renal artery [44] . For the renal artery, endovascular revascu larization using the percutaneous transluminal angio plasty technique or surgical procedures are considered when the patients show hypertension resistant to a regimen of three antihypertension drugs, including diuretics, or in cases of renal artery aneurysm or renal artery dissection [2, 4, 38] . Thus far, no randomized clinical trials of revascularization vs medication have been conducted. For other arteries, including the carotid artery, given that FMD is not an atherosclerotic disease, stenting or surgical procedures are not the standard therapy, and medication with antiplatelet, anticoagulant, and anti hypertensive agents are the main treatment. However, when symptomatic, interventional radiology using the percutaneous transluminal angioplasty technique can be considered, although it is controversial [38] . In our case summary, open surgery was performed on 23 patients (59%) and endovascular intervention was performed on 9 patients (23%).
Prognosis
Though the prognosis is basically good, when FMD af fects the cerebrovascular system, there is a risk of cere bral infarction and rupture. A larger number of cases are necessary to accumulate the information useful to conduct randomized clinical trials.
SEGMENTAL ARTERIAL MEDIOLYSIS
Clinical characteristics
Segmental arterial mediolysis (SAM) was first reported by Slavin and GonzalezVitale in 1976 [45] and is a rare disease entity for which 50 cases have been reported to date. It is defined as a nonatherosclerotic, noninflammatory disruption of the arterial medial layer of a medium to largesized artery. Histologically, it is characterized as vacuolization and lysis of the outer arterial media [45] . Because of its rarity and difficulty in differential diagnosis from the other vascular diseases, clinical information is insufficient, and little is known to date; however, no significant predominance of sex or age has been reported. The mechanisms underlying the pathogenesis of SAM that have been reported as risk factors are hypoxia, shock, aging, hypertension, circulatory disturbance, arteriospasm, and other vaso constrictor stimuli [4547] .
Symptoms and imaging
For the abdominal lesion, the most common symptom is nonspecific abdominal and flank pain [46] ; diarrhea, nausea, back pain, headache, hypertension, loss of con sciousness, and hemiparesis have also been known to be symptoms, although not specific [47] . We reviewed the literature describing the cases and have summarized the information in Table 2 [4771]
. The studies reported a total of 26 cases of mesenteric SAM, of which 17 were men and 9 were women, with a slight predominance in men. The median age was 53 years (range: 2579 years). The most common presenting symptom was abdominal pain (78%), followed by various symptoms, including shock, diarrhea, nausea, back pain, headache, anorexia, hypertension, hemiparesis, and loss of consciousness ( Table 2) .
With the development of various imaging modalities, it has been reported that, in various combinations, SAM typically affects splenic, celiac, hepatic, mesenteric, and renal arteries in the abdominal lesion [47, 72] . Because of the involvement of the celiac artery, splenic arterial aneurysm is frequently found, and its rupture could affect the prognosis. Angiography reveals aneurysms, dissections, occlusions, and stenosis; however, the findings could overlap with those found in collagen vascular diseases and FMD. Therefore, the differential diagnoses between the vascular diseases are based on the histopathological findings. SAM is difficult to distinguish from FMD, al though FMD shows predominance in young women and affects renal arteries causing hypertension, whereas SAM commonly affects the celiac arteries. In addition, the clinical course shows ischemic changes in FMD, whereas SAM often causes profuse bleeding from the intestinal arteries. However, these findings often overlap each other; therefore, accumulation of more detailed information is necessary.
Histology
Although the suspicion of SAM is the basis of clinical and radiological features, the gold standard for diagnosis is a pathological finding involving injurious and reparative phases in the arterial lesions of the surgical specimens. These injurious states include mediolysis, separation of the outer media, and formation of arterial gaps; key is that there is no evidence of inflammation. These changes reflect the vascular aneurysms frequently found as angiographic features of this condition. Commonly, the inflammatory markers are negative and genetic diag nosis for collagen vascular disorders shows a normal pattern.
Treatment
The longterm prognosis is unclear, and no standard therapeutic strategy has been proposed, to date; how ever, given that some SAM cases showed sudden the onset of aneurysm rupture, the condition could be life threatening. Therefore, SAM treatment includes embolization, bypass, and resection of the injured arteries. In addition, antihypertensive therapy [28] could prevent further worsening of the arterial lesions. Anti . In addition, given it is a noninflammatory disorder, no evidence of efficacy in use of antiinflammatory agents or immunosuppressive agents has been reported. However, SAM has been treated with these agents when the differential diagnosis from the other arteritis was difficult [70] .
For patients presenting acutely with intraabdominal hemorrhage, patients are treated with emergent catheter angiography, endovascular intervention, or surgical treatment [73] . Shenouda reported that coil embolization was the most common endovascular intervention and was reported as successful in 88% of patients, with no mortality, whereas the open surgical approach was associated with a 9% mortality rate [72] . In our patient summary, open surgery was most commonly performed, and this was performed on 13 patients (50%). Endovascular intervention was performed on eight patients (31%), and anticoagulation therapy was administered to two patients (7.7%), including warfarin and aspirin administration. Antihypertensive therapy was administered to one patient with Cablocker.
Prognosis
Although the prognosis of the disease is reported to be good when managed appropriately [72] , SAM can be fatal when ruptured [49, 73] . Therefore, a careful diagnosis and appropriate management are essential for this disease entity. Our case summary also showed that although 24 (92%) patients improved, 2 (7.7%) patients died, 1 having had a large hematoma and a ruptured aneurysm in the mesenteric lesion that was revealed upon the emergent surgery.
DISCUSSION
The inner wall of a normal artery is smooth and in the normal condition, blood flows through it without difficulty. The major cause of decreasing the blood flow is atherosclerosis which is due to the deposits of fatty materials, such as cholesterol, developing the thickened arterial walls and stenosis of the vasculatures. These changes cause ischemic changes in the organs fed by the vasculatures and if it occurred in the abdominal mesenteric lesions, the symptoms of severe abdominal pain, ischemic changes of the intestine could be observed leading to lethality. For other vascular diseases including aneurysm, occlusion, and thromboses in the mesenteric lesions could cause severe symptoms and appropriate diagnosis and treatment are essential for managing patients. With the development and improvement of imaging modalities, including CT and magnetic resonance imaging, the frequency of diagnosis of vascular disease in abdominal lesions is increasing. Among these, FMD and SAM are known as noninflammatory, nonatherosclerotic arterial diseases, difficult to be differentially diagnosed from each other. Although various arteries are involved in these diseases, we have focused on the mesenteric areas, reviewing cases in this study and summarizing the clinical characteristics of both disease entities (Table 3) .
The histologic findings and the imaging findings of FMD and SAM are similar; for example, Lie proposed that SAM can represent a precursor of certain types of FMD [74] .
Slavin and colleagues also proposed that SAM could represent a precursor of FMD, although a part of SAM might remain as unspecified aneurysms [46] . Although these similarities in radiological and histological diagnoses have been reported, the two entities exhibit a different clinical profile in terms of age of onset, sex, distribution of affected arteries, and clinical symptoms. Although FMD affects middleaged women, there is no predilection for age or sex in SAM [2, 73] .
Considering the mesenteric lesions, as there are no specific symptoms, a greater knowledge and comprehensive understanding of these diseases are important for appropriate diagnosis and treatment. For example, FMD rarely shows significant symptoms and is frequently associated with symptoms of occlusive disease such as renovascular hypertension, headache, and pulsatile tinnitus. Although FMD does not rupture as often, SAM shows hemorrhages resulting from arterial rupture or dissection from the weakened arterial wall [4, 46] and is therefore symptomatic with acute abdominal and flank pain.
CONCLUSION
Mesenteric vascular diseases are rare compared with other disease entities in lesions; therefore, clinical infor mation is insufficient and clinical trials to develop the standard therapy are lacking. Therefore, an accumulation of cases and a summary of the clinical characteristics of reported cases are important. For this purpose, we have summarized the characteristics of FMD and SAM in abdominal lesions. This information could help physicians to appropriately diagnose and treat cases, including consultation with interventional radiologists and surgeons.
Fibromuscular dysplasia Segmental arterial mediolysis
Gender Female (9:1) [2] No presentation [74] Age of presentation Young to middle age [2] No preference [74] Laboratory findings No serological markers [74] No serological markers [74] Risk factors Smoking and extracranial arteries [4] Hypoxia and shock or other vasoconstrictor stimuli [47] Vascular distribution Renal and extracranial arteries [4] Celiac and mesenteric arteries [48] CT Alternating stenosis and aneurysms, less commonly dissections [38] Dissections with alternating stenosis and aneurysms, dissecting aneurysms [48] Angiography Beaded aneurysmal appearance (string-of-beads) [38] Beaded aneurysmal appearance (string-of-beads) [38] Pathology Fibrous or fibromuscular thickening of the arterial wall [38] Vecuolization and lysis of the outer media [47] Symptoms Renovascular hypertension, Headache, Pulsatile tinnitus [4] Acute abdominal pain, Intraperitoneal bleeding [47] Treatment Anti-platelet therapy and anti-hypertensive therapy. Balloon angioplasty and stenting [45] Anti-hypertensive therapy and endovascular management, surgical management [74] 
